Endovascular

View the latest content related to this topic

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

The graft should no longer be used to treat blunt traumatic aortic injury given the risk of thrombosis or occlusion, says Cook Medical.

Michael O'Riordan

August 17, 2017

Slides

See all

Presentation

VIVA 2017

5-year EVAR Outcomes Are Equivalent Between Genders: Results from the ENGAGE Registry

Presenter: Marc Schermerhorn

September 21, 2017

Presentation

VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

Presentation

VIVA 2017

Drug-coated Balloons Show Superior Four-Year Outcomes versus Angioplasty: Results from the IN.PACT SFA Randomized Trial

Presenter: Peter A. Schneider

September 15, 2017

Presentation

VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

Presentation

VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

News

See all

News • Interventional

Carotid Revascularizations Declining as Outcomes Improve, Medicare Data Show

By L.A. McKeown

September 20, 2017

News • Interventional

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

By Caitlin E. Cox

September 19, 2017

News • Interventional

VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

By L.A. McKeown

September 18, 2017

News • Interventional

VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

By L.A. McKeown

September 15, 2017

News • Interventional

VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

By L.A. McKeown

September 14, 2017

Fellows 2017

April 6

April 09, 2017

ISET 2017

February 4

February 08, 2017

Videos on This Topic

See all

Video

Transradial Access for Subclavian, Innominate, and Carotid Artery Disease

November 1, 2016

Advertisement

Endovascular

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Slides

5-year EVAR Outcomes Are Equivalent Between Genders: Results from the ENGAGE Registry

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Drug-coated Balloons Show Superior Four-Year Outcomes versus Angioplasty: Results from the IN.PACT SFA Randomized Trial

Two-year Results from the IN.PACT Global Study

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

News

Carotid Revascularizations Declining as Outcomes Improve, Medicare Data Show

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

EVAR Outcomes Equivalent Between Men and Women, Registries Show

More on This Topic

Upcoming Conferences

TCT 2017

Conference Coverage

Fellows 2017

ISET 2017

Videos on This Topic

Transradial Access for Subclavian, Innominate, and Carotid Artery Disease

Advertisement

Advertisement

Endovascular

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content